Concepedia

Author

Cheryl D. Bradshaw

Esperion Therapeutics (United States)

Also Known As

Cheryl D Bradshaw, Cheryl D. Bradshaw

4

Publications

311

Citations

2

H-Index

14

Concepts

All Affiliations

Esperion Therapeutics (United States)
CD

About

Cheryl D. Bradshaw is an author at Esperion Therapeutics (United States) specializing in oxidative stress, atherosclerosis, and immune regulation.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

1

1

84

2

Cell Biology

1

1

84

3

Immunology

1

1

84

4

Pharmacology

1

1

84

5

Autoimmunity

1

1

84

Cheryl D. Bradshaw

×

2

Publications

309

Citations

2

H-Index

YearCitations

AMP-activated protein kinase and ATP-citrate lyase are two distinct molecular targets for ETC-1002, a novel small molecule regulator of lipid and carbohydrate metabolism

Stephen L. Pinkosky, Jeffrey C. Hanselman, Cheryl D. Bradshaw,

Journal of Lipid Research

2012

225

ETC-1002 regulates immune response, leukocyte homing, and adipose tissue inflammation via LKB1-dependent activation of macrophage AMPK

Stephen L. Pinkosky, Richard J. Lister, Catherine Pawloski,

Journal of Lipid Research

2013

84

Page 1